We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Published online by Cambridge University Press: 05 April 2015
INTRODUCTION
Focal liver lesions that are assigned this clinical setting of low or no suspicion of malignancy are likely to be “incidentalomas” discovered in asymptomatic patients during health screening, or in symptomatic patients undergoing investigations for nonhepatic-related conditions. Most of them are small and will eventually turn out to be benign. Not all focal liver lesions discovered during staging or follow-up surveillance of cancer patients are due to metastases either. Regular ultrasound surveillance of patients with hepatitis B and C cirrhosis has led to an increasing number of small hepatocellular nodular lesions being detected.
Benign focal lesions are frequently detected during imaging of the liver. Most benign tumors can be characterized on ultrasound, computerized tomography (CT), and magnetic resonance imaging (MRI) with corroborative clinical information and demonstration of typical imaging characteristics and normal background parenchyma, such as hemangioma and focal nodular hyperplasia (FNH). Differentiating benign from malignant entities may be difficult when they show atypical or overlapping imaging features. Hepatocellular adenomas (HCAs), owing to their variable appearances, often present diagnostic difficulties and are the most common benign tumor to undergo biopsy confirmation. Rare tumors, such as angiomyolipoma, often simulate metastases and other primary hepatic lesions on imaging. Some hepatocellular nodules that are associated with cirrhosis may carry a higher index of suspicion and are, hence, aspirated or biopsied.
When clinical and radiologic features concur, the role of biopsy is twofold: (i) for definitive characterization of the benign lesion, and (ii) to refute the remote possibility of malignancy. For practical purposes, solid focal liver lesions in this clinical setting are addressed under pattern/ cell profile, namely, hepatocellular, glandular/biliary, mesenchymal, and hematopoietic/inflammatory patterns. The diagnostic algorithm is given in Table 4.1. Benign cystic lesions are discussed in Chapter 8.
TUMORS AND TUMOR-LIKE LESIONS WITH HEPATOCELLULAR PATTERN
In association with normal liver
Focal fatty change
CLINICAL FEATURES
The liver shows single or multiple, geographic, or nodular areas of fatty change.
To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.
